Moreover, we demonstrated that the loss of BRG-1 correlates with a lack of CD44 expression by influencing the methylation of the CD44 promoter in colorectal cancer cell lines, which could be restored in the presence of 5-aza. The gene discussed is SMARCA4; the disease is colorectal cancer.